SL Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,829
| Closed | -$190K | – | 38 |
|
|
2024
Q3 | $190K | Buy |
+1,829
| New | +$186K | 0.34% | 38 |
|
|
2023
Q3 | – | Sell |
-2,704
| Closed | -$208K | – | 45 |
|
|
2023
Q2 | $208K | Hold |
2,704
| – | – | 0.47% | 44 |
|
|
2023
Q1 | $203K | Hold |
2,704
| – | – | 0.44% | 50 |
|
|
2022
Q4 | $213K | Buy |
+2,704
| New | +$203K | 0.47% | 49 |
|
|
2022
Q3 | – | Sell |
-2,704
| Closed | -$217K | – | 47 |
|
|
2022
Q2 | $217K | Buy |
2,704
+14
| +0.5% | +$1.09K | 0.52% | 46 |
|
|
2022
Q1 | $204K | Sell |
2,690
-48
| -2% | -$3.8K | 0.42% | 46 |
|
|
2021
Q4 | $234K | Sell |
2,738
-718
| -21% | -$56.1K | 0.58% | 44 |
|
|
2021
Q3 | $261K | Sell |
3,456
-61
| -2% | -$4.84K | 0.66% | 43 |
|
|
2021
Q2 | $286K | Sell |
3,517
-30
| -0.8% | -$2.45K | 0.73% | 42 |
|
|
2021
Q1 | $280K | Sell |
3,547
-717
| -17% | -$56.2K | 0.85% | 41 |
|
|
2020
Q4 | $365K | Sell |
4,264
-309
| -7% | -$25.6K | 1.18% | 34 |
|
|
2020
Q3 | $353K | Buy |
4,573
+969
| +27% | +$73.9K | 1.29% | 31 |
|
|
2020
Q2 | $264K | Sell |
3,604
-253
| -7% | -$18K | 1% | 34 |
|
|
2020
Q1 | $256K | Sell |
3,857
-2,673
| -41% | -$189K | 1.11% | 35 |
|
|
2019
Q4 | $450K | Sell |
6,530
-38
| -0.6% | -$2.59K | 1.11% | 34 |
|
|
2019
Q3 | $483K | Sell |
6,568
-638
| -9% | -$46.3K | 0.93% | 37 |
|
|
2019
Q2 | $516K | Sell |
7,206
-21
| -0.3% | -$1.49K | 0.89% | 38 |
|
|
2019
Q1 | $495K | Sell |
7,227
-247
| -3% | -$16K | 0.77% | 43 |
|
|
2018
Q4 | $445K | Sell |
7,474
-47
| -0.6% | -$2.94K | 0.92% | 40 |
|
|
2018
Q3 | $503K | Buy |
7,521
+1,414
| +23% | +$94.2K | 0.93% | 36 |
|
|
2018
Q2 | $396K | Sell |
6,107
-2,487
| -29% | -$163K | 0.89% | 37 |
|
|
2018
Q1 | $616K | Sell |
8,594
-660
| -7% | -$47.5K | 1.23% | 36 |
|
|
2017
Q4 | $698K | Sell |
9,254
-460
| -5% | -$33.6K | 1.19% | 36 |
|
|
2017
Q3 | $708K | Buy |
9,714
+46
| +0.5% | +$3.31K | 0.32% | 43 |
|
|
2017
Q2 | $717K | Sell |
9,668
-191
| -2% | -$14.2K | 0.37% | 42 |
|
|
2017
Q1 | $722K | Buy |
9,859
+51
| +0.5% | +$3.57K | 0.41% | 43 |
|
|
2016
Q4 | $642K | Sell |
9,808
-409
| -4% | -$28K | 0.43% | 44 |
|
|
2016
Q3 | $754K | Sell |
10,217
-3,011
| -23% | -$223K | 0.61% | 38 |
|
|
2016
Q2 | $968K | Buy |
+13,228
| New | +$942K | 0.9% | 36 |
|
Other funds holding CL
SL Advisors's CL Position: Q4 2024 in Review
SL Advisors sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 1,829 shares — an estimated $190K sold.
SL Advisors first reported a position in CL in Q2 2016 and held it in 29 quarters. The position peaked at $968K in Q2 2016. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.
- SL Advisors reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
- SL Advisors sold 1,829 Colgate-Palmolive shares in Q4 2024, an estimated $190K.
- SL Advisors first reported a position in Colgate-Palmolive in Q2 2016 and held it in 29 quarters.
- SL Advisors's Colgate-Palmolive position peaked at $968K in Q2 2016.
- 1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.
Based on SL Advisors's 13F filing for Q4 2024, filed 8 Jan 2025.